[ Xontogeny raises $15M in Series A ]
Xontogeny has raised $15 million in Series A funding.
Founded in 2016, Xontogeny is a biotechnology accelerator that focuses on the early development of pharmaceuticals and technologies for the life science industries.The accelerator is assembling a senior team of life science professionals with deep experience in drug development to advance a select portfolio of product candidates and technologies in ventures that are focused across a number of serious disease areas from preclinical through clinical proof-of-concept studies.
The company will use the proceeds from this financing to manage operations, build its team of experts, and advance early stage development of life science products in its portfolio companies.
|Founder / CEO||Chris Garabedian|